trofosfamide has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartscht, T; Biersack, H; Fetscher, S; Gebauer, N; Lehnert, H; Mayer, T; Merz, H; Rades, D; Riecke, A; Witte, HM | 1 |
| Herr, W; Reichle, A; Schelker, RC; Vogelhuber, M | 1 |
| Bechrakis, NE; Coupland, SE; Fischer, L; Jahnke, K; Korfel, A; Thiel, E; Wagner, T; Willerding, G | 1 |
3 other study(ies) available for trofosfamide and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Frail Elderly; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Progression-Free Survival; Remission Induction; Rituximab; Treatment Outcome | 2019 |
Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Retrospective Studies; Rituximab | 2018 |
Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Disease-Free Survival; Eye Neoplasms; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prospective Studies; Salvage Therapy | 2005 |